Is Orchestra BioMed Holdings, Inc. (OBIO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 6.8% / 30% | 27.4% / 30% | 0.0% / 30% | 127.22% / 5% | ✗ NOT HALAL |
| DJIM | 6.8% / 33% | 27.4% / 33% | 0.0% / 33% | 127.22% / 5% | ✗ NOT HALAL |
| MSCI | 21.7% / 33% | 87.7% / 33% | 0.1% / 33% | 127.22% / 5% | ✗ NOT HALAL |
| S&P | 6.8% / 33% | 27.4% / 33% | 0.0% / 33% | 127.22% / 5% | ✗ NOT HALAL |
| FTSE | 21.7% / 33% | 87.7% / 33% | 0.1% / 50% | 127.22% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 99.4% | |
| Operating Margin | 21.8% | |
| Net Margin | -157.4% | |
| Return on Equity (ROE) | -109.4% | |
| Return on Assets (ROA) | -33.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$49M |
| Free Cash Flow | -$49M |
| Total Debt | $16M |
| Debt-to-Equity | 25.2 |
| Current Ratio | 6.4 |
| Total Assets | $115M |
Price & Trading
| Last Close | $4.49 |
| 50-Day MA | $4.21 |
| 200-Day MA | $3.63 |
| Avg Volume | 216K |
| Beta | 0.6 |
|
52-Week Range
$2.20
| |
About Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral vascular disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Orchestra BioMed Holdings, Inc. (OBIO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Orchestra BioMed Holdings, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Orchestra BioMed Holdings, Inc.'s debt ratio?
Orchestra BioMed Holdings, Inc.'s debt ratio is 6.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 21.7%.
What are Orchestra BioMed Holdings, Inc.'s key financial metrics?
Orchestra BioMed Holdings, Inc. has a market capitalization of $249M, and revenue of $33M. The company maintains a gross margin of 99.4% and a net margin of -157.4%. Return on equity stands at -109.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.